President Trump spared pharmaceuticals from the opening salvo in his campaign to transform the economy through “reciprocal” ...
16h
24/7 Wall St. on MSN4 Blue Chip Pharmaceutical High-Yield Dividend Stocks Are Tariff WinnersLarge-cap pharmaceutical stocks like these may now be positioned to outperform as the impact of tariffs begins to take hold.
Pharma stocks plummet as Trump signals steep tariffs on India's drug exports, with concerns over higher costs and profit ...
The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...
Trump previously floated a 25% tariff on all imported drugs, though they were unaffected by recent reciprocal levies.
ORLANDO, Fla., April 04, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (the “Company”) (NASDAQ:NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it has signed an ...
Donald Trump has imposed 10 per cent tariffs on all of the United Kingdom’s exports to the United States. There are higher ...
6h
TheJournal.ie on MSNBotox and Viagra: Are Ireland’s most famous pharma exports safe from the impacts of tariffs?ARE IRELAND’S MOST well-known pharma exports safe from the impacts of tariffs, or could products like Botox and Viagra face ...
The direct impact of higher US tariffs on India looks fluid as of now and a mutually beneficial trade deal by the end of this ...
Stock analysts at Leerink Partnrs raised their FY2028 EPS estimates for shares of Cencora in a note issued to investors on ...
President Trump wants to bring pharmaceutical manufacturing back to the U.S. Experts warn tariffs could result in shortages ...
Eupraxia Pharmaceuticals (NASDAQ:EPRX – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Monday, April 7th. Analysts expect Eupraxia Pharmaceuticals to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results